Iron in Nonhemochromatotic Liver Disorders
The DOI matches its Crossref record.
Abstract
Iron is essential for cellular functions, but in excessive amounts it is toxic to cells. The harmful effects are related to increased oxidative stress and production of reactive oxygen species causing oxidative damage to lipids, proteins, and nucleic acids. Heavy iron overload as occurs in primary and secondary hemochromatosis can cause fibrosis of various parenchymal organs such as the liver, heart, and pancreas. Lesser degrees of hepatic iron deposition are also associated with, and seem to be risk factors for, certain nonhemochromatotic liver diseases. Porphyria cutanea tarda is associated with hepatic iron overload and responds to iron-reduction therapy. Other recent evidence indicates that the prevalence of HFE gene mutations is increased in chronic viral hepatitis and that patients with chronic hepatitis C harboring especially the C282Y mutation are more likely to suffer from advanced hepatic fibrosis or cirrhosis and to do so at younger ages. In this article we review selected nonhemochromatotic disorders in which iron can play an important comorbid role.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“hepatitis C”
From Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson’s, Huntington’s, Alzheimer’s, prions, bactericides, chemical toxicology and others as examples (2010) · cites this paper as Alla and Bonkovsky 2005
Citations
Cites
Still being checked.
Cited by
Zelber-Sagi, S., Nitzan-Kaluski, D., Goldsmith, R., Webb, M., Blendis, L., Halpern, Z., & Oren, R. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.06.020 · Cited by 551
Kell, D. B. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0577-x · Cited by 361
“…Beck et al. 2004), herpes simplex virus (Gennero et al. 2010; Lamey and Biagioni 1995; Romeo et al. 2001), hepatitis C (Alavian and Tabatabaei 2009; Alla and Bonkovsky 2005; Ameli et al. 2008; Bassett 2007; Batts 2007; Bonkovsky 2002; Bonkovsky et al. 2006; Desai et al. 2008; Di Marco et al. 2008;…”
BackgroundMiura, K., Taura, K., Kodama, Y., Schnabl, B., & Brenner, D. A. (2008) · Hepatology · doi:10.1002/hep.22486 · Cited by 270
A precious metal: Iron, an essential nutrient for all cells
Cairo, G., Bernuzzi, F., & Recalcati, S. (2006) · Genes & Nutrition · doi:10.1007/bf02829934 · Cited by 257
Preza, G. C., Ruchala, P., Pinon, R., Ramos, E., Qiao, B., Peralta, M. A., Sharma, S., Waring, A., Ganz, T., & Nemeth, E. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57693 · Cited by 234
Metadata
- Authors
- Alla, V., & Bonkovsky, H. L.
- Affiliations
- UConn Health (US)
- ORCID
- Bonkovsky, Herbert L
- Venue
- Seminars in Liver Disease
- Publisher
- Georg Thieme Verlag KG
- Published
- 2005
- Volume
- 25
- Issue
- 04
- Pages
- 461-472
- ISSN
- 0272-8087 (ISSN-L)
- 1098-8971
- OpenAlex
- W1992239176
- Cited by
- 124
- References
- 0
- Citations by year
- 2026: 1 · 2024: 1 · 2023: 5 · 2022: 4 · 2021: 1 · 2020: 2 · 2019: 4 · 2018: 2 · 2017: 1 · 2016: 3 · 2015: 6 · 2014: 4 · 2013: 7 · 2012: 13
- FWCI
- 6.72
- Type
- journal article
- Language
- de
- Open access
- closed
- Locations
- Seminars in Liver Disease (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5u01dk065193-05, n01dk92326-28-0-1)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK038825, R01-DK-38825, UO1 DK065193, N01 DK 92326)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Keywords
- iron overload, oxidative stress, reactive oxygen species, liver fibrosis, liver cirrhosis, porphyria cutanea tarda, HFE gene mutations, C282Y mutation, chronic hepatitis C, chronic viral hepatitis, hepatic iron deposition
- MeSH terms
- Fatty Liver, Hepatitis C, Humans, Iron, Liver Cirrhosis, Risk Factors, Porphyria Cutanea Tarda, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Iron in Nonhemochromatotic Liver Disorders. https://app.cochat.ai/papers/10.1055/s-2005-923317
- The paper
- Alla, V., & Bonkovsky, H. L. (2005). Iron in Nonhemochromatotic Liver Disorders. Seminars in Liver Disease. https://doi.org/10.1055/s-2005-923317
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.